PARTNERS 

EVI recognises the power of collaboration and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine research and development (R&D). 

OUR PARTNERS
Global network for worldwide impact

arrow&v
Abbott

The Netherlands

Projects:

FLUCOP

Abbott

Areas:

Cross-cutting

Artemis Bio-Support B.V.

The Netherlands

Projects:

FLUCOP

Artemis Bio-Support B.V.

Areas:

Cross-cutting

AstraZeneca AB

Sweden

Projects:

FLUCOP

AstraZeneca AB

Areas:

Cross-cutting

Austrian Agency for Health and Food Safety Ltd. (AGES)

Austria

Projects:

VAC2VAC

Austrian Agency for Health and Food Safety Ltd. (AGES)

Areas:

Cross-cutting

BIOASTER - Fondation de Cooperation Scientifique

France

Projects:

TRANSVAC2, TRANSVAC-DS

BIOASTER - Fondation de Cooperation Scientifique

Areas:

Cross-cutting

Batavia Biosciences B.V.

The Netherlands

Projects:

CEPI-Nipah

Batavia Biosciences B.V.

Areas:

Nipah virus disease

Bavaria Nordic

Denmark

Projects:

VAC2VAC

Bavaria Nordic

Areas:

Cross-cutting

Beijing Science and Technology Linkedin CO LTD, S&T

China

Projects:

SENET

Beijing Science and Technology Linkedin CO LTD, S&T

Areas:

Cross-cutting

Beijing University of Chinese Medicine (BUCM)

China

Projects:

SENET

Beijing University of Chinese Medicine (BUCM)

Areas:

Cross-cutting

Biomedical Primate Research Centre (BPRC)

The Netherlands

Projects:

TRANSVAC2, TRANSVAC-DS, VAC2VAC, FLUCOP

Biomedical Primate Research Centre (BPRC)

Areas:

Cross-cutting

Contact us

We'd love to hear from you!

For the latest updates follow EVI on:

  • LinkedIn
  • Twitter
  • YouTube